Kriya Therapeutics

Developing gene therapies for prevalent chronic diseases.

BiotechnologyGene Therapy kriyatx.com ↗

Company facts

Founded
2019
Employees
189
Headquarters
United States
Type
Private
Funding
Series D · $320M · 2025
Subsidiaries
Redpin Therapeutics, Tramontane Therapeutics